Correction: Fluocinolone acetonide 0.2 µg/day intravitreal implant in non-infectious uveitis affecting the posterior segment: EU expert user panel consensus-based clinical recommendations
J Ophthalmic Inflamm Infect
.
2025 Jan 8;15(1):1.
doi: 10.1186/s12348-024-00450-w.
Authors
Uwe Pleyer
1
,
Carlos Pavesio
2
,
Elisabetta Miserocchi
3
,
Carsten Heinz
4
5
,
Helen Devonport
6
,
Víctor Llorenç
7
8
,
Tomás Burke
9
,
Vanda Nogueira
10
,
Laurent Kodjikian
11
12
,
Bahram Bodaghi
13
Affiliations
1
Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
[email protected]
.
2
Department of Ophthalmology at Moorfields Eye Hospital, London, UK.
3
Department of Ophthalmology, Ocular Immunology and Uveitis Service, University Vita-Salute, IRCCS San Raffaele Scientific Institute, Milan, Italy.
4
Department of Ophthalmology at St, Franziskus Hospital Muenster, Münster, Germany.
5
Department of Ophthalmology, University Duisburg-Essen, Essen, Germany.
6
Bradford Teaching Hospitals NHS Foundation Trust, Bradford, West Yorkshire, UK.
7
Clínic Hospital of Barcelona, Barcelona, Spain.
8
August Pi I Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
9
Department of Ophthalmology, Mater Misericordiae University Hospital, Dublin, Ireland.
10
Instituto de Oftalmologia Dr. Gama Pinto, Lisbon, Portugal.
11
Service d'Ophtalmologie, Hôpital Universitaire de La Croix-Rousse, Hospices Civils de Lyon, Lyon, 69004, France.
12
UMR5510 MATEIS, CNRS, INSA Lyon, Université Lyon 1, Villeurbanne, 69100, France.
13
Department of Ophthalmology, Pitié-Salpêtrière Hospital, Paris, France.
PMID:
39775675
DOI:
10.1186/s12348-024-00450-w
No abstract available
Publication types
Published Erratum